4-Bromo-2-(2,2,2-trifluoroethyl)-2,3-dihydropyridazin-3-one, >95%, 1g

3,4-dihydropyrimidine-4-thione, 97%, 5g

6-Bromo-1H-indole-4-carbonitrile, 95+%, 500mg

Ethyl 5-(2-iodophenyl)-5-oxovalerate, 97.0%, 2g

1-(m-Tolyl)imidazoline-2-thione, 1g

Tetrachlorethylene, min. 99.5%, for synthesis, 1 L, glass packaging

3-(Trifluoromethyl)phenacyl bromide, 98.0%, 10g

3,3'-Di(9H-carbazol-9-yl)-1,1'-biphenyl (purified by sublimation)>99.0%(HPLC)(N)200mg

3-cyclopropyl-6-piperazin-1-yl[1,2,4]triazolo[4,3-b]pyridazine, 95.0%, 500mg

2-Chloro-2-nitropropane, 250mg

1-(tetrahydro-2H-pyran-4-yl)-3-piperidinecarboxylic acid hydrochloride, 95.0%, 1g

4-Amino-6-iodo-2-methylpyrimidine, 95.0%, 1g

(S)-6,6'-Dibromo-2,2'-bis(methoxymethoxy)-1,1'-binaphthyl, 98%, 25g